Skip to content

Meet us at COP31Read more

Bristol-Myers Squibb Co Sustainability Reports

Bristol-Myers Squibb Company is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, and marketing of innovative medicines. The company primarily targets serious diseases across therapeutic areas such as oncology, cardiovascular health, immunology, and neuroscience.

Sector: Manufacturing

Country: United States

Exchange: New York Stock Exchange

LEI: HLYYNH7UQUORYSJQCN42

FIGI: BBG001S8N8J6

49 reports from 1995 to 2025